Redspeed excellent digging! LYMPRO "is there" as Rubinfeld stated. Others are still working out the details, and fine-tuning in the lab. As was pointed out, there are commonly a number of available treatments for various diseases, and diagnostics as well. BUT being the FIRST to market has a big advantage! Gerald and the AMBS BOD/BOA understand the dynamics perfectly, and have delivered! LYMPRO is now available, and we will see how it is received by BP. Competition is limited at this point, there isn't any. Looking forward to details on LYMPRO Expanded LP-002 Study of Alzheimer's Blood Diagnostic LymPro Test(R) to Assess Predictive Value in Early-Stage Disease. Gerald will have the attention of BP on the Jan 14 and the JPM conference coming up............